ReviewPublished 12 October 2026Obesity-driven inflammation and immune dysregulation in cancer development and progressionPritika Pandey · Jeb F. Struder · Erika T. Rezeli · Evan M. Paules · Stephen D. Hursting · Michael F. Coleman · Kristin A. AltweggFrontiers in Oncologydoi 10.3389/fonc.2026.1947958
CorrectionPublished 12 October 2026Correction: Effect and mechanism of Emodin on mouse myeloid-derived suppressor cellsFrontiers Production OfficeFrontiers in Pharmacologydoi 10.3389/fphar.2026.2001607
ReviewPublished 23 September 2026Immunosuppressive cell populations as potential drivers of extrinsic immune checkpoint inhibition resistance in clear cell renal cell carcinomaUsman Humayun TemuriOncology Reviewsdoi 10.3389/or.2026.1953850
